105 related articles for article (PubMed ID: 8590364)
1. Familial risk factors for a second primary malignancy in endometrial or ovarian carcinoma.
Shiromizu K; Araki J; Onda T; Nishimura T; Takahashi M; Matsuzawa M
J Obstet Gynaecol (Tokyo 1995); 1995 Jun; 21(3):269-72. PubMed ID: 8590364
[TBL] [Abstract][Full Text] [Related]
2. [The coexistence of endometrial cancer with second primary malignant neoplasms].
Studziński Z; Branicka D
Ginekol Pol; 1999 Apr; 70(4):186-92. PubMed ID: 10582403
[TBL] [Abstract][Full Text] [Related]
3. Familial association of specific histologic types of ovarian malignancy with other malignancies.
Lorenzo Bermejo J; Rawal R; Hemminki K
Cancer; 2004 Apr; 100(7):1507-14. PubMed ID: 15042686
[TBL] [Abstract][Full Text] [Related]
4. [The analysis of coexistence of endometrial cancer with other malignant and benign neoplasms with endometriosis].
Studziński Z; Branicka D
Ginekol Pol; 1998 May; 69(5):273-8. PubMed ID: 9695326
[TBL] [Abstract][Full Text] [Related]
5. [The analysis of the coexistence of endometrial carcinoma and uterine myoma].
Studziński Z; Filipczak A; Branicka D
Ginekol Pol; 2000 Mar; 71(3):123-9. PubMed ID: 10842912
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of clinical manifestations of familial adenomatous polyposis.
Sohrabi AK; Nowzari P
W V Med J; 1992 May; 88(5):193-4. PubMed ID: 1318618
[TBL] [Abstract][Full Text] [Related]
7. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
[TBL] [Abstract][Full Text] [Related]
10. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
11. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
[TBL] [Abstract][Full Text] [Related]
12. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications.
Casey MJ; Bewtra C; Lynch HT; Snyder CL; Stacey M
Int J Gynecol Cancer; 2015 May; 25(4):650-6. PubMed ID: 25756400
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
[TBL] [Abstract][Full Text] [Related]
17. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
18. Familial clustering of ovarian and endometrial cancers.
Hemminki K; Granström C
Eur J Cancer; 2004 Jan; 40(1):90-5. PubMed ID: 14687794
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1.
Maruyama A; Miyamoto S; Saito T; Kondo H; Baba H; Tsukamoto N
Cancer; 2001 Jun; 91(11):2056-64. PubMed ID: 11391585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
